类风湿性关节炎（rheumatoid arthritis，RA）是一种致残率极高、临床治愈率低的自身免疫性疾病，被认为是一种多因素参与、多基因改变协同作用的结果。如何有效治疗RA值得医药界研究人员的探讨。随着中医药技术的发展，基因芯片技术已从基础研究逐步应用于新药研发和临床诊断，为进一步研究治疗RA提供了新的思路及方法。

Rheumatoid arthritis (RA) is an autoimmune diseases of high morbidity and low clinical cure rate, which is considered to be the results of multi-factor and multi-gene interacting. It is worth for the researchers in pharmaceutical field to explore how effective treatment of RA. With the development of traditional Chinese medine technology, gene chip and other advanced technology have been gradually applied to new drug discovery and clinical diagnosis from basic research with providing a new approach of thought and method for RA further research.